Google trend - Evotec

Evotec - 10 things to know with detail

• Company background: Evotec is a drug discovery and development company based in Germany. It was founded in 1993 and has since grown to become a leading player in the pharmaceutical industry.
• Focus on drug discovery: Evotec specializes in discovering and developing new drugs for a variety of therapeutic areas, including neurology, oncology, and infectious diseases.
• Collaborations with pharma companies: Evotec partners with pharmaceutical companies to accelerate the drug discovery process. Some of its partners include Bayer, Boehringer Ingelheim, and Celgene.
• Technologies and platforms: Evotec utilizes a range of cutting-edge technologies and platforms in its drug discovery efforts, including high-throughput screening, fragment-based drug discovery, and computational chemistry.
• Target-based and phenotypic drug discovery: Evotec employs both target-based and phenotypic drug discovery approaches to identify new drug candidates. This allows the company to explore a wide range of potential drug targets and mechanisms of action.
• Drug development pipeline: Evotec has a robust drug development pipeline with multiple programs in various stages of development. The company focuses on advancing promising drug candidates through preclinical and clinical development.
• Acquisition of Just Biotherapeutics: In 2019, Evotec acquired Just Biotherapeutics, a biologics development company based in the United States. This acquisition expanded Evotec's capabilities in biologics drug discovery and development.
• Strategic partnerships: Evotec has established strategic partnerships with academic institutions, research organizations, and biotech companies to collaborate on innovative drug discovery projects. These partnerships help to leverage the expertise and resources of multiple stakeholders.
• Drug discovery services: In addition to its own drug discovery efforts, Evotec also offers drug discovery services to external partners. These services include target identification, hit finding, lead optimization, and preclinical development.
• Commitment to innovation: Evotec is committed to driving innovation in drug discovery and development. The company continuously invests in research and development to advance novel therapies for unmet medical needs.